Cedar Fair Q3 EPS $5.86 Beats $3.86 Estimate, Sales $843.06M Miss $864.67M Estimate

Cedar Fair (NYSE:FUN) reported quarterly earnings of $5.86 per share which beat the analyst consensus estimate of $3.86 by 51.81 percent. This is a 125.38 percent increase over earnings of $2.60 per share from the same

Cedar Fair (NYSE:FUN) reported quarterly earnings of $5.86 per share which beat the analyst consensus estimate of $3.86 by 51.81 percent. This is a 125.38 percent increase over earnings of $2.60 per share from the same period last year. The company reported quarterly sales of $843.06 million which missed the analyst consensus estimate of $864.67 million by 2.50 percent. This is a 11.90 percent increase over sales of $753.40 million the same period last year.

Total
0
Shares
Related Posts
Read More

Fear & Greed Index Remains In ‘Greed’ Zone; US Stocks Notch 4th Consecutive Weekly Gain

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, with the index remaining in the "Greed" zone on Friday. U.S. stocks closed mixed in the holiday-shortened trading session on Friday, ahead of the major shopping season. Meanwhile, all three major indices recorded their fourth straight weekly gains.

AMZN

Read More

MangoRx Introduces “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate And Pregnenolone For Treatment Of Low Testosterone And Male Hormone Imbalances; Sold Exclusively On MangoRx’s Website On A Subscription Basis At A Price Of $199…

MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testosterone Replacement Therapy (TRT)Dallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) --

MGRX